Cancer BiologyNature CommunicationsPeer-reviewed
Novel synthetic ecteinascidins exhibit potent anti-melanoma activity by suppressing super-enhancer-driven oncogenic transcription
Max Cigrang, Julian Obid, Maguelone Nogaret…·Frédéric Coin
This study shows novel synthetic ecteinascidins effectively treat melanoma by inhibiting super-enhancer-driven oncogenic transcription, even in resistant models.
16 citations